SAN DIEGO--(BUSINESS WIRE)--MultiCell Technologies, Inc. (OTCBB:MCET), developing first-in-class drugs based on modulation of the immune system, will release an audio interview with Dr. Stephen Chang, President and Chief Executive Officer of MultiCell, on Monday, October 16, at 12 noon Eastern.
